Merck & Co. Inc. (MRK)

58.55
0.59 1.00
NYSE : Health Technology
Prev Close 59.14
Open 59.18
Day Low/High 58.45 / 59.32
52 Wk Low/High 52.83 / 66.41
Volume 5.28M
Avg Volume 11.24M
Exchange NYSE
Shares Outstanding 2.69B
Market Cap 159.27B
EPS 0.90
P/E Ratio 67.90
Div & Yield 1.92 (3.18%)

Latest News

4 Names to Buy in a Refreshed Biotech Space

4 Names to Buy in a Refreshed Biotech Space

After a strong week for the biotech sector, these names have potential catalysts to move shares.

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

Healthcare Stocks Rebound After President Trump's Speech on Drug Pricing

President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.

CVS Health, Prestige Brands, LendingTree: 'Mad Money' Lightning Round

CVS Health, Prestige Brands, LendingTree: 'Mad Money' Lightning Round

Jim Cramer takes a look at CVS Health, Prestige Brands, LendingTree, Valeant Pharmaceuticals, Nektar Therapeutics, Kirkland Lake and more.

Buffett's Optimism Rules: Cramer's 'Mad Money' Recap (Monday 5/7/18)

Buffett's Optimism Rules: Cramer's 'Mad Money' Recap (Monday 5/7/18)

Jim Cramer says Warren Buffett is the greatest investor, and his optimism has suffused trading and has been justified.

Surveying the M&A Landscape in Biotech

Surveying the M&A Landscape in Biotech

Who might be in play in the quarters ahead?

Merck Provides Update On KEYNOTE-407 Trial

null

Dow Declines as S&P 500 and Nasdaq Finish Higher

Dow Declines as S&P 500 and Nasdaq Finish Higher

Stocks were mixed on Tuesday with investors adopting a cautious stance as the Federal Reserve begins a two-day meeting.

Don't Throw in the Towel on Merck After Earnings Selloff

Don't Throw in the Towel on Merck After Earnings Selloff

Let's take a look at the charts and indicators to see what may lie ahead for this drug maker.

Apple, BP, Boeing, Pfizer and Merck - 5 Things You Must Know

Apple, BP, Boeing, Pfizer and Merck - 5 Things You Must Know

U.S. stock futures are mixed as the Federal Reserve kicks off a two-day meeting and Apple is scheduled to report quarterly results.

Wall Street Futures Edge Lower, Oil Holds Gains; Markets Await Apple Earnings

Wall Street Futures Edge Lower, Oil Holds Gains; Markets Await Apple Earnings

Global stocks bumped higher Tuesday, while oil prices held at three-and-a-half year highs, amid several key market closures and ahead of what could be a crucial quarterly earnings update from Apple after the close of trading.

Are Apple's Best Days in the Past?: Market Recon

Are Apple's Best Days in the Past?: Market Recon

I think it very possible that there will be a positive reaction tonight, more likely based on what Tim Cook says.

Financial Highlights Package

null

Fighting Crosswinds: Cramer's 'Mad Money' Recap (Friday 4/27/18)

Fighting Crosswinds: Cramer's 'Mad Money' Recap (Friday 4/27/18)

Jim Cramer says foolish traders believe a trade war will trigger a recession, but they're wrong. Fight the crosswinds with a game plan for next week.

What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week

What to Expect From Allergan, Aetna, Merck and Pfizer's Earnings Next Week

The drugmakers and health insurer are preparing to unveil first-quarter numbers.

Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business

Fate of Pfizer Unit in Spotlight After Merck Sells Consumer Business

Procter & Gamble, which is buying the Merck unit, was previously reported to be in talks to acquire Pfizer's consumer healthcare business.

Intermediate Trade: Merck

Intermediate Trade: Merck

2018 should be the beginning of Merck's earnings return to growth.

Asia Benchmarks Sag; U.S. Stock Futures Edge Higher

Asia Benchmarks Sag; U.S. Stock Futures Edge Higher

Asia markets traded mostly lower Tuesday, with Hong Kong's benchmark down almost 500 points.

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Dow Jumps 212 Points as Wall Street Shrugs Off Syria and Turns to Earnings

Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

The Worst Stock Market Plunge in Your Lifetime Is Coming: Jim Rogers

The Worst Stock Market Plunge in Your Lifetime Is Coming: Jim Rogers

Legendary investor Jim Rogers thinks the market is headed straight for a major sell off. Here's why.

Jim's Daily Rundown

Today, Jim discusses Raytheon, tensions in Syria, bank earnings, Kohl's, Nordstrom and more!

Merck Notches Key Win Over Bristol-Myers on Lung Cancer Study Data

Merck Notches Key Win Over Bristol-Myers on Lung Cancer Study Data

The drugmakers on April 16 released data from their respective studies at the Association for Cancer Research's annual meeting in Chicago.

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

U.S. Senator Cory Booker Criticizes Pharma Companies in New Tax Report

The Trump Administration cut corporate taxes and U.S. Senator Cory Booker hoped pharma companies would cut drug prices. That didn't happen and Booker's new analysis hammers those drug companies.

TheStreet Quant Rating: C (Hold)